13F Portfolios

Commodore Capital LP — TYRA BIOSCIENCES INC TYRA: Quarterly 13F Position History

Commodore Capital LP has reported TYRA BIOSCIENCES INC (TYRA) on 5 13F-HR filings in Pactolio's tracked window, first appearing in Q1 2025. As of Q1 2026, the position is sized at 2,475,000 shares ($94.8M market value, 5.48% of the equity book). Quarter-over-quarter share count change: 900,000 (-26.7%) .

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 5 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 2,475,000 900,000 -26.7% $94.8M 5.48% $38.30
Q4 2025 3,375,000 0 $88.7M 5.91% $26.29
Q3 2025 3,375,000 +275,000 +8.9% $47.2M 2.31% $13.99
Q2 2025 3,100,000 +2,150,000 +226.3% $29.7M 2.09% $9.57
Q1 2025 950,000 $8.8M 0.65% $9.30

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did Commodore Capital LP first disclose a TYRA position in 13F-HR filings?

Commodore Capital LP first reported TYRA BIOSCIENCES INC (TYRA) on its 13F-HR filing for the period ending 2025-03-31 (Q1 2025). The position has appeared on 5 reported quarters within Pactolio's tracked window.

What was Commodore Capital LP's most recent quarter-over-quarter share-count change in TYRA?

Between Q4 2025 and Q1 2026, Commodore Capital LP reduced its TYRA position by 900,000 shares (-26.7%), leaving 2,475,000 shares at a market value of $94.8M.

Does the implied price-per-share represent Commodore Capital LP's cost basis in TYRA?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.